| Stiripentol | hsa00030 | Pentose phosphate pathway | 2.27E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | |
| Stiripentol | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | |
| Stiripentol | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | |
| Stiripentol | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | |
| Stiripentol | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | |
| Stiripentol | hsa04072 | Phospholipase D signaling pathway | 2.75E-02 | 3 | P61586, O14986, P63092 | RHOA, PIP5K1B, GNAS | More | |
| Stiripentol | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | |
| Stiripentol | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | |
| Stiripentol | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | |
| Stiripentol | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | |
| Stiripentol | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | |
| Stiripentol | hsa04612 | Antigen processing and presentation | 2.21E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | |
| Stiripentol | hsa04621 | NOD-like receptor signaling pathway | 4.31E-02 | 4 | P01375, P59665, P59666, P12838 | TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Stiripentol | hsa04640 | Hematopoietic cell lineage | 1.58E-02 | 6 | P13612, P20023, P11836, P09693, P01732, P13765 | ITGA4, CR2, MS4A1, CD3G, CD8A, HLA-DOB | More | |
| Stiripentol | hsa04650 | Natural killer cell mediated cytotoxicity | 1.28E-02 | 6 | P20963, Q13241, P26718, O14931, P26717, P26715 | CD247, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | |
| Stiripentol | hsa04658 | Th1 and Th2 cell differentiation | 1.36E-02 | 5 | P20963, P09693, P23771, Q9UL17, P13765 | CD247, CD3G, GATA3, TBX21, HLA-DOB | More | |
| Stiripentol | hsa04659 | Th17 cell differentiation | 3.36E-02 | 5 | P13765, Q9UL17, P23771, P09693, P20963 | HLA-DOB, TBX21, GATA3, CD3G, CD247 | More | |
| Stiripentol | hsa04660 | T cell receptor signaling pathway | 1.58E-02 | 6 | O95267, Q08881, P20963, P09693, P01732, Q13191 | RASGRP1, ITK, CD247, CD3G, CD8A, CBLB | More | |
| Stiripentol | hsa04672 | Intestinal immune network for IgA production | 4.27E-02 | 2 | P13765, P13612 | HLA-DOB, ITGA4 | More | |
| Stiripentol | hsa04713 | Circadian entrainment | 4.94E-02 | 2 | P62873, P63092 | GNB1, GNAS | More | |
| Stiripentol | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | |
| Stiripentol | hsa04724 | Glutamatergic synapse | 3.65E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | |
| Stiripentol | hsa04726 | Serotonergic synapse | 2.52E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | |
| Stiripentol | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Stiripentol | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | |
| Stiripentol | hsa05032 | Morphine addiction | 9.04E-05 | 5 | P62873, P48169, P78334, P63092, P32298 | GNB1, GABRA4, GABRE, GNAS, GRK4 | More | |
| Stiripentol | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | |
| Stiripentol | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
| Stiripentol | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Stiripentol | hsa05163 | Human cytomegalovirus infection | 2.09E-02 | 4 | P62873, P61586, P63092, P61769 | GNB1, RHOA, GNAS, B2M | More | |
| Stiripentol | hsa05169 | Epstein-Barr virus infection | 3.10E-02 | 7 | P20023, P13765, Q92769, O00463, P24522, P09693, P20963 | CR2, HLA-DOB, HDAC2, TRAF5, GADD45A, CD3G, CD247 | More | |
| Stiripentol | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | |
| Stiripentol | hsa05217 | Basal cell carcinoma | 2.83E-02 | 3 | Q13635, Q9UJU2, P24522 | PTCH1, LEF1, GADD45A | More | |
| Stiripentol | hsa05321 | Inflammatory bowel disease | 3.98E-02 | 3 | P13765, Q9UL17, P23771 | HLA-DOB, TBX21, GATA3 | More | |
| Stiripentol | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Stiripentol | hsa05332 | Graft-versus-host disease | 1.62E-03 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | |
